What is Rigel Pharmaceuticals's revenue?

Rigel Pharmaceuticals (RIGL) generated $299.8M in revenue over the trailing twelve months, up 47.6% year over year.

Is Rigel Pharmaceuticals profitable?

Rigel Pharmaceuticals reported $364.2M in net income over the trailing twelve months, a 121.5% net margin.

What are Rigel Pharmaceuticals's profit margins?

Gross margin is 93.4% and operating margin is 41.6%, with a 121.5% net margin.

What is Rigel Pharmaceuticals's earnings per share?

Rigel Pharmaceuticals's diluted EPS over the trailing twelve months is $19.28.

Where does Rigel Pharmaceuticals's income statement data come from?

Every line is extracted from Rigel Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Rigel Pharmaceuticals RIGL Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	$299.77M+47.6%	$294.28M+64.1%	$282.08M+79.1%	$267.92M+106%	$203.08M+68.7%
Total cost of revenue	$19.82M-5.8%	$19.62M+5.2%	$19.46M+16.9%	$22.73M+130%	$21.03M+158%
Gross profit	$279.95M+53.8%	$274.66M+71.0%	$262.62M+86.5%	$245.19M+104%	$182.05M+62.3%
Gross margin	93.4%+3.7pp	93.3%+3.7pp	93.1%+3.7pp	91.5%-0.9pp	89.6%-3.6pp
Research and development	$36.54M+41.7%	$33.3M+42.4%	$28.24M+34.9%	$27.07M+27.5%	$25.79M+26.1%
Selling, general and administrative	$118.84M+5.8%	$115.9M+2.5%	$115.43M+4.6%	$113.54M+4.9%	$112.33M+5.5%
Total costs & expenses	$175.19M+10.1%	$168.82M+8.9%	$163.13M+10.2%	$163.33M+17.2%	$159.15M+17.8%
Operating income	$124.58M+184%	$125.47M+419%	$118.95M+1,478%	$104.59M+1,052%	$43.93M+363%
Operating margin	41.6%+19.9pp	42.6%+29.1pp	42.2%+37.4pp	39%+47.5pp	21.6%+35.5pp
Interest expense	$6.9M-12.6%	$7.32M-7.6%	$7.58M-3.7%	$7.74M+0.4%	$7.9M+4.7%
Income before income taxes	$121.97M+220%	$121.83M+563%	$114.34M+3,754%	$99.14M+554%	$38.12M+241%
Income tax expense	-$242.26M-25,709%	-$245.2M-27,932%	$1.04M—	$1.32M—	$946K—
Net income	$364.23M+880%	$367.02M+1,999%	$113.3M+3,504%	$97.82M+753%	$37.18M+281%
Net margin	121.5%+103pp	124.7%+115pp	40.2%+38.2pp	36.5%+48.0pp	18.3%+35.4pp
Diluted earnings per share	$19.28+827%	$19.47+1,887%	$6.18+1,388%	$5.42+459%	$2.08+214%
EBITDA	$126.99M+174%	$127.88M+384%	$121.37M+1,184%	$107.01M+1,240%	$46.36M+401%
EBITDA margin	42.4%+19.5pp	43.5%+28.7pp	43%+37.0pp	39.9%+47.1pp	22.8%+35.6pp
EBIT	$124.58M+184%	$125.47M+419%	$118.95M+1,478%	$104.59M+1,052%	$43.93M+363%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Rigel Pharmaceuticals.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rigel Pharmaceuticals's revenue?: Rigel Pharmaceuticals (RIGL) generated $299.8M in revenue over the trailing twelve months, up 47.6% year over year.
Is Rigel Pharmaceuticals profitable?: Rigel Pharmaceuticals reported $364.2M in net income over the trailing twelve months, a 121.5% net margin.
What are Rigel Pharmaceuticals's profit margins?: Gross margin is 93.4% and operating margin is 41.6%, with a 121.5% net margin.
What is Rigel Pharmaceuticals's earnings per share?: Rigel Pharmaceuticals's diluted EPS over the trailing twelve months is $19.28.
Where does Rigel Pharmaceuticals's income statement data come from?: Every line is extracted from Rigel Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.